Chlamydia infection status, genotype, and age-related macular degeneration

Molecular Vision

Volumn 18, Issue , 2012, Pages 29-37

  Khandhadia, Sam ^a   Foster, Sebastian ^b   Cree, Angela ^a   Griffiths, Helen ^a   Osmond, Clive ^c   Goverdhan, Srinivas ^a,d   Lotery, Andrew ^a,d  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGE; AGED; ARTICLE; BACTERIUM IDENTIFICATION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHLAMYDOPHILA PSITTACI; COMPLEMENT FACTOR H GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HIGH TEMPERATURE REQUIREMENT SERINE PEPTIDASE 1 GENE; HOMOZYGOSITY; HUMAN; IMMUNOFLUORESCENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; WILD TYPE;

AGED; CASE-CONTROL STUDIES; CHLAMYDIA; CHLAMYDIA INFECTIONS; COMPLEMENT FACTOR H; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOZYGOTE; HUMANS; IMMUNOGLOBULIN G; MACULAR DEGENERATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; RETINA; RISK FACTORS; SERINE ENDOPEPTIDASES; SEVERITY OF ILLNESS INDEX;

EID: 84856807457     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Congdon N, O'Colmain B, Klaver CC, Klein R, Munoz B, Friedman DS, Kempen J, Taylor HR, Mitchell P. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004; 122:477-85. [PMID: 15078664]
2. Foran S, Wang JJ, Mitchell P. Causes of incident visual impairment: the Blue Mountains Eye Study. Arch Ophthalmol 2002; 120:613-9.[PMID: 12003611]
3. Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF, de Jong PT. The prevalence of agerelated maculopathy in the Rotterdam Study. Ophthalmology 1995; 102:205-10.[PMID: 7862408]see comment
4. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of agerelated maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995; 102:1450-60.[PMID: 9097791]Review 26 refs
5. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992; 99:933-43.[PMID: 1630784]
6. Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Gangnon RE. Fifteen-year cumulative incidence of agerelated macular degeneration: the Beaver Dam Eye Study. Ophthalmology 2007; 114:253-62.[PMID: 17270675]
7. Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004; 137:486-95.[PMID: 15013873]
8. Klein R, Knudtson MD, Cruickshanks KJ, Klein BE. Further observations on the association between smoking and the long-term incidence and progression of age-related macular degeneration: the Beaver Dam Eye Study. Arch Ophthalmol 2008; 126:115-21. [PMID: 18195228]
9. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308:385-9. [PMID: 15761122]
10. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, Schnetz-Boutaud N, Agarwal A, Postel EA, Pericak-Vance MA. Complement factor H variant increases the risk of agerelated macular degeneration. Science 2005; 308:419-21.[PMID: 15761120]
11. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and agerelated macular degeneration. Science 2005; 308:421-4.[PMID: 15761121]
12. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005; 102:7227-32.[PMID: 15870199]
13. Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, Shahid H, Clayton DG, Hayward C, Morgan J, Wright AF, Armbrecht AM, Dhillon B, Deary IJ, Redmond E, Bird AC, Moore AT. Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 2007; 357:553-61.[PMID: 17634448]
14. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, Chen H, Zhao Y, Pearson E, Li X, Chien J, Dewan A, Harmon J, Bernstein PS, Shridhar V, Zabriskie NA, Hoh J, Howes K, Zhang K. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006; 314:992-3.[PMID: 17053109]
15. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K, Cramer K, Neel J, Bergeron J, Barile GR, Smith RT, Hageman GS, Dean M, Allikmets R, Chang S, Yannuzzi LA, Merriam JC, Barbazetto I, Lerner LE, Russell S, Hoballah J, Hageman J, Stockman H. Variation in factor B (BF) and complement component 2 (C2) genes is associated with agerelated macular degeneration. Nat Genet 2006; 38:458-62.[PMID: 16518403]
16. Hageman GS, Hancox LS, Taiber AJ, Gehrs KM, Anderson DH, Johnson LV, Radeke MJ, Kavanagh D, Richards A, Atkinson J, Meri S, Bergeron J, Zernant J, Merriam J, Gold B, Allikmets R, Dean M. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann Med 2006; 38:592-604.[PMID: 17438673]
17. Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of agerelated macular degeneration. Nat Genet 2006; 38:1173-7.[PMID: 16998489]
18. Thakkinstian A, Han P, McEvoy M, Smith W, Hoh J, Magnusson K, Zhang K, Attia J. Systematic review and metaanalysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum Mol Genet 2006; 15:2784-90.[PMID: 16905558]Review 60 refs
19. Ault BH. Factor H and the pathogenesis of renal diseases. Pediatr Nephrol 2000; 14:1045-53.[PMID: 10975323]
20. Müller-Eberhard HJ, Schreiber RD. Molecular biology and chemistry of the alternative pathway of complement. Adv Immunol 1980; 29:1-53.[PMID: 6158260]
21. Cortes C, Ferreira VP, Pangburn MK. Native properdin binds o Chlamydia pneumoniae and promotes complementactivation. Infect Immun 2011; 79:724-31.[PMID: 21134964]
22. Hall RT, Strugnell T, Wu X, Devine DV, Stiver HG. Characterization of kinetics and target proteins for binding of human complement component C3 to the surface-exposed outer membrane of Chlamydia trachomatis serovar L2. Infect Immun 1993; 61:1829-34.[PMID: 8478073]
23. Lin JS, Yan LL, Ho Y, Rice PA. Early complement components enhance neutralization of Chlamydia trachomatis infectivity by human sera. Infect Immun 1992; 60:2547-50.[PMID: 1587622]
24. Brooks GF. Jawetz, Melnick, and Adelberg-Æs Medical Microbiology (24th Edition). Blacklick, OH: McGraw-Hill Medical Publishing Division; 2007.
25. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen V. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2:983-6.[PMID: 2902492]
26. Thom DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992; 268:68-72.[PMID: 1608116]
27. Linnanmäki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993; 87:1130-4.[PMID: 8484830]
28. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. South African Medical Journal Suid-Afrikaanse Tydskrif Vir Geneeskunde 1992; 82:158-61.[PMID: 1519134]
29. Kuo CC, Gown AM, Benditt EP, Grayston JT. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb 1993; 13:1501-4.[PMID: 7691166]
30. Skowasch D, Yeghiazaryan K, Schrempf S, Golubnitschaja O, Welsch U, Preusse CJ, Likungu JA, Welz A, Luderitz B, Bauriedel G. Persistence of Chlamydia pneumoniae in degenerative aortic valve stenosis indicated by heat shock protein 60 homologues. J Heart Valve Dis 2003; 12:68-75.[PMID: 12578339]
31. Dreses-Werringloer U, Bhuiyan M, Zhao Y, Gerard HC, Whittum-Hudson JA, Hudson AP. Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain. International Journal of Medical Microbiology 2009; 299:187-201.[PMID: 18829386]
32. Fainardi E, Castellazzi M, Seraceni S, Granieri E, Contini C. Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis. Curr Neurovasc Res 2008; 5:60-70.[PMID: 18289023]
33. Kalayoglu MV, Galvan C, Mahdi OS, Byrne GI, Mansour S. Serological association between Chlamydia pneumoniae infection and age-related macular degeneration. Arch Ophthalmol 2003; 121:478-82.[PMID: 12695244]
34. Miller DM, Espinosa-Heidmann DG, Legra J, Dubovy SR, Suner IJ, Sedmak DD, Dix RD, Cousins SW, Miller DM, Espinosa-Heidmann DG, Legra J, Dubovy SR, Suner IJ, Sedmak DD, Dix RD, Cousins SW. The association of prior cytomegalovirus infection with neovascular age-related macular degeneration. Am J Ophthalmol 2004; 138:323-8. [PMID: 15364212]
35. Klein R, Klein BE, Knudtson MD, Wong TY, Shankar A, Tsai MY, Klein R, Klein BEK, Knudtson MD, Wong TY, Shankar A, Tsai MY. Systemic markers of inflammation, endothelial dysfunction, and age-related maculopathy. Am J Ophthalmol 2005; 140:35-44.[PMID: 15939388]
36. Kalayoglu MV, Bula D, Arroyo J, Gragoudas ES, D'Amico D, Miller JW, Kalayoglu MV, Bula D, Arroyo J, Gragoudas ES, D'Amico D, Miller JW. Identification of Chlamydia pneumoniae within human choroidal neovascular membranes secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2005; 243:1080-90.[PMID: 15909160]
37. Robman L, Mahdi O, McCarty C, Dimitrov P, Tikellis G, McNeil J, Byrne G, Taylor H, Guymer R. Exposure to Chlamydia pneumoniae infection and progression of agerelated macular degeneration. Am J Epidemiol 2005; 161:1013-9.[PMID: 15901621]
38. Kessler W, Jantos CA, Dreier J, Pavlovic S, Kessler W, Jantos CA, Dreier J, Pavlovic S. Chlamydia pneumoniae is not detectable in subretinal neovascular membranes in the exudative stage of age-related macular degeneration. Acta Ophthalmol Scand 2006; 84:333-7.[PMID: 16704694]
39. Robman L, Mahdi OS, Wang JJ, Burlutsky G, Mitchell P, Byrne G, Guymer R, Taylor H. Exposure to Chlamydia pneumoniae infection and age-related macular degeneration: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci 2007; 48:4007-11.[PMID: 17724180]
40. Baird PN, Robman LD, Richardson AJ, Dimitrov PN, Tikellis G, McCarty CA, Guymer RH. Gene-environment interaction in progression of AMD: the CFH gene, smoking and exposure to chronic infection. Hum Mol Genet 2008; 17:1299-305.[PMID: 18203751]
41. Haas P, Steindl K, Schmid-Kubista KE, Aggermann T, Krugluger W, Hageman GS, Binder S. Complement factor H gene polymorphisms and Chlamydia pneumoniae infection inage-related macular degeneration. Eye (Lond) 2009; 23:2228-32. [PMID: 19169230]
42. Shen D, Tuo J, Patel M, Herzlich AA, Ding X, Chew EY, Chan CC. Chlamydia pneumoniae infection, complement factor H variants and age-related macular degeneration. Br J Ophthalmol 2009; 93:405-8.[PMID: 18996904]
43. Enzmann V, Hess R, Jordi F, Wolf S, Wolf-Schnurrbusch UEK. Detection of Chlamydia Pneumoniae and Factors of the Complement System in Neovascular Membranes of Patients With Age-Related Macular Degeneration. ARVO Annual Meeting; 2010 May 2-6; Fort Lauderdale (FL).
44. Fujimoto T, Sonoda KH, Hijioka K, Sato K, Takeda A, Hasegawa E, Oshima Y, Ishibashi T. Choroidal neovascularization enhanced by Chlamydia pneumoniae via Toll-like receptor 2 in the retinal pigment epithelium. Invest Ophthalmol Vis Sci 2010; 51:4694-702.[PMID: 20393111]
45. Haas P. Chlamydia Pneumoniae Infection and Complement Factor H Gene Polymorphism in Age-Related Macular Degeneration - Is There an Association? ARVO Annual Meeting; 2008 April 27-May 1; Fort Lauderdale (FL).
46. Morré SA, Van Valkengoed IG, Moes RM, Boeke AJ, Meijer CJ, Van den Brule AJ. Determination of Chlamydia trachomatis prevalence in an asymptomatic screening population: performances of the LCx and COBAS Amplicor tests with urine specimens. J Clin Microbiol 1999; 37:3092-6.[PMID: 10488159]
47. Wilson JS, Honey E, Templeton A, Paavonen J, Mårdh PA, Stray-Pedersen B. EU Biomed Concerted Action Group. A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update 2002; 8:385-94[PMID: 12206472]
48. Harkinezhad T, Verminnen K, De BM, Rietzschel E, Bekaert S, Vanrompay D. Prevalence of Chlamydophila psittaci infections in a human population in contact with domestic and companion birds. J Med Microbiol 2009; 58:1207-12.[PMID: 19528151]
49. Tong Y, Liao J, Zhang Y, Zhou J, Zhang H, Mao M. LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis. Mol Vis 2010; 16:1958-81.[PMID: 21031019]
50. Goverdhan SV, Hannan S, Newsom RB, Luff AJ, Griffiths H, Lotery AJ. An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment. Eye (Lond) 2008; 22:849-54.[PMID: 17464302]
51. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 2001; 132:668-81.[PMID: 11704028]
52. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215.[PMID: 3344216]
53. Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, Hammerschlag MR, Jackson LA, Kuo CC, Maass M, Messmer TO, Talkington DF, Tondella ML, Zaki SR. Workshop Participants Cp. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001; 33:492-503.[PMID: 11462186]
54. Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, Hammerschlag MR, Jackson LA, Kuo CC, Maass M, Messmer TO, Talkington DF, Tondella ML, Zaki SR. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001; 33:492-503.[PMID: 11462186]
55. Persson K, Boman J. Comparison of five serologic tests for diagnosis of acute infections by Chlamydia pneumoniae. Clin Diagn Lab Immunol 2000; 7:739-44.[PMID: 10973447]
56. Villegas E, Sorlozano A, Gutierrez J. Serological diagnosis of Chlamydia pneumoniae infection: limitations and perspectives. J Med Microbiol 2010; 59:1267-74.[PMID: 20724512]